Efficacy and Safety of Targeted Immunotherapies for Moderate to Severe Palmoplantar Pustulosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Targeted immunotherapy for moderate-to-severe palmoplantar pustulosis: a network meta-analysis of randomized controlled trials
J Am Acad Dermatol 2024 Jul 04;[EPub Ahead of Print], YC Tsai, FL Hsu, TF TsaiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.